Aveanna Healthcare Hldgs (AVAH) closed at $11.01 on November 20, 2026, up 2.9% from the previous close, on volume of 1,965,653 shares (30-day average 2,152,332).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days
TipRanks (Wed, 18-Nov 10:30 AM ET)
UBS Sticks to Its Hold Rating for Aveanna Healthcare Holdings (AVAH)
TipRanks (Mon, 16-Nov 8:55 AM ET)
Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2026 Guidance
Globe Newswire (Thu, 12-Nov 7:00 AM ET)
Aveanna Announces Third Quarter 2026 Earnings Release Date and Conference Call
Globe Newswire (Thu, 22-Oct 6:30 AM ET)
Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit
Globe Newswire (Thu, 27-Aug 7:00 AM ET)
Aveanna to Participate in the 2026 Jefferies Healthcare Services and Technology Conference
Globe Newswire (Tue, 25-Aug 7:00 AM ET)
Aveanna Healthcare Raises 2026 Revenue Outlook After Double-Digit Q2 Growth
Market Chameleon (Thu, 13-Aug 7:15 AM ET)
Market Chameleon (Thu, 13-Aug 3:52 AM ET)
Aveanna Healthcare Raises 2026 Guidance Amid 26% Surge in Adjusted EBITDA
Market Chameleon (Fri, 15-May 6:18 AM ET)
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Aveanna Healthcare Hldgs trades on the NASDAQ stock market under the symbol AVAH.
As of November 20, 2026, AVAH stock price climbed to $11.01 with 1,965,653 million shares trading.
AVAH has a beta of 0.40, meaning it tends to be less sensitive to market movements. AVAH has a correlation of 0.02 to the broad based SPY ETF.
AVAH has a market cap of $2.40 billion. This is considered a Mid Cap stock.
Last quarter Aveanna Healthcare Hldgs reported $696 million in Revenue and $.23 earnings per share. This beat revenue expectation by $14 million and exceeded earnings estimates by $.03.
In the last 3 years, AVAH traded as high as $14.71 and as low as $2.00.
The top ETF exchange traded funds that AVAH belongs to (by Net Assets): VTI, IWM, FESM, VXF, DFAS.
AVAH has outperformed the market in the last year with a return of +32.7%, while the SPY ETF gained +6.9%. However, in the most recent history, AVAH shares have underperformed the stock market with its stock returning -15.1% in the last 3 month period and -16.9% for the last 2 week period, while SPY has returned -9.3% and -6.2%, respectively.
AVAH support price is $10.33 and resistance is $11.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVAH shares will trade within this expected range on the day.